secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2023-08-14T23:59:59+00:00
Accession:  0000950170-23-042070
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larimar Therapeutics posts updated investor presentation; no financial results disclosed
--------------------------------------------------------------------------------

- Company posted an updated slide presentation on its website on August 14, 2023 for use in investor meetings.
- No new financial guidance, clinical data, or material business developments were disclosed in the 8-K.
- The presentation is filed as Exhibit 99.1 but its full content is not available in the provided text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000095017023042070/0000950170-23-042070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000095017023042070/lrmr-20230814.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-042070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer